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Low incidence of ras oncogene activation in human squamous cell
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Summary Activation of the ras gene family by point mutation at codons 12, 13 and 61 has been demon-
strated in up to 20% of unselected series of human tumours. The present study was carried out to assess the
incidence of ras activation in 37 squamous cell carcinomas of the head and neck, seven squamous cell
carcinomas of the skin and eight squamous carcinoma cell lines. Oligonucleotide probes and the polymerase
chain reaction were used on DNA extracted from achival paraffin embedded material. Mutations in codon 12
of the Harvey ras gene were found in a carcinoma of the larynx and a carcinoma of the lip, both of which had
received prior irradiation. A cell line (LICR-LON-HN8) established from the same laryngeal cancer showed
the same mutation. This study indicates that there is a low incidence of ras mutation in human squamous cell
carcinomas and that activation of this family of genes is probably not a common factor in the development of
this group of tumours.
This laboratory has had a long-term interest in studies of
differentiation and transformation in squamous carcinomas
of the head and neck. To this end a panel of squamous
carcinoma cell lines has been developed for in vitro and in
vivo analysis (Easty et al., 1981a, b). Raised levels of PHCG
production have been demonstrated by the tumour cell lines
compared with normal keratinocytes (Cowley et al., 1985),
along with a number of tumour associated characteristics,
including the production of osteolytic factors (Carter, 1985;
Burman & Carter, 1985, 1988), an increase in some cell
surface glycoproteins (Rayter et al., 1989) and raised levels of
epidermal growth factor receptors (Cowley et al., 1984;
Gusterson et al., 1984; Ozanne et al., 1986). These well-
documented cell lines when combined with parallel analyses
of primary tumour material provide a valuable resource for
studies of oncogene expression within this well defined group
of tumours.
In the murine skin carcinogenesis model an A-T transver-
sion in codon 61 of the ras gene is an early event in the
production of murine skin cancers by chemical carcinogens
(Quintanilla et al., 1986). In humans there is some
epidemiological support for the view that chemical car-
cinogens are important in the aetiology of mucosal squamous
carcinomas of the head and neck, suggesting that, by analogy
with the animal model, an analysis of ras gene mutations in
these human tumours may show some evidence of ras activa-
tion. We have thus carried out a detailed study of ras muta-
tions on DNA extracted from both squamous carcinoma cell
lines and tumours taken from these sites.
There is some evidence that ultraviolet light induced skin
carcinomas in mice express an activated K-ras oncogene
(Strickland et al., 1985) and more recently three out of eight
human squamous cell carcinomas, arising in sun exposed
areas (Ananthaswamy et al., 1988), have been shown to have
activated H-ras genes. An H-ras mutation has also been
described in keratoacanthoma, a benign regressing skin lesion
which has many characteristics of a squamous cell carcinoma
(Leon et al., 1988). There appear to have been no publica-
tions indicating the effects of ionising radiation on human
oral epithelium or skin although mouse thymomas with
activated K-ras genes have been found in radiation-induced
mouse thymomas (Guerrero et al., 1984) and rat skin
tumours (Saway et al., 1987). y-irradiation is a common
treatment for squamous cell carcinomas of the head and neck
and half of the cases used in this study had been treated
in this way, as had all the tumour biopsies from which the
cells lines were established. Any correlation of ras activation
with previous irradiation could thus be investigated.
A direct method of detecting point mutation of the ras
oncogene in tumours is provided by enzymatic amplification
of DNA by the polymerase chain reaction (PCR) technique
(Saiki et al., 1985). The method makes use of oligonucleotide
primers to amplify a small region of the gene of interest
several thousand-fold, followed by differential oligonucleotide
hydridisation to determine single nucleotide changes from the
normal (wild-type) gene sequence at selected sites. As only
small amounts of low molecular weight DNA are required,
the technique is particularly suited to both the quality and
quantity of material extracted from paraffin embedded tissue.
We have applied this technique, using probes corresponding
to wild-type and mutated ras sequences, to DNA from
archival material and cell line extracts.
Material and methods
Normal and tumour tissue was collected at the time of
surgery, fixed in formal saline and embedded in paraffin wax.
Sections of 5 ,im were cut for histological analysis. The
tumour samples were from the sites indicated in Table I. The
squamous carcinoma cell lines used were established from
previously irradiated tumours (Table II). There were 37 head
and neck squamous carcinomas (male 31, female 6; age
29-84, median 57; 19 tumours treated with y-irradiation
before biopsy) and seven skin squamous carcinomas (male 3,
female 4; six arose in sun exposed sites).
Table I Squamous carcinomas of the head and neck
Site ofprimary tumour No.
Oral cavity (tongue I 1, floor of mouth 3, lip 1) 15
Oropharynx, hypopharynx, cervical oesophagus I1
Larynx 9
Paranasal sinuses 2
Table II Squamous carcinoma cell lines (n = 8)
LICR-LON-HN5 Tongue
LICR-LON-HN6
R Tongue, right sided recurrence
SM Metastasis in submandibular lymph node
LICR-LON-HN8 Larynx
LICR-LON-HN9 Tongue
LICR-LON-HNIO Larynx
LICR-LON-HN1 1 Floor of mouth
LICR-LON-HN16 Hypopharynx
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DNA preparation
DNA was isolated from tissue sections without prior removal
of paraffin wax as follows. Eight 30tim sections were cut
from each block, inserted into bijoux bottles and broken up
using forceps. One ml digestion buffer (100 mmol 1' Tris
HCI, pH 8; 40 mmol 1-' EDTA, 10 mmol 1' NaCl, 0.1% SDS
and 0.4 mg ml-' proteinase K) was added and samples were
incubated overnight at 48°C. An additional 0.5 ml digestion
buffer was then added and sections were incubated for a
further 24 h at the same temperature. Following extraction
with equal volumes of phenol (twice), phenol: chloroform:
isoamyl alcohol (25:24:1) (once), chloroform: isoamyl alcohol
(24:1) (twice), the aqueous phase was made 0.1 M with
respect to NaCl and DNA precipitated by the addition of
two volumes of ethanol. Quantitation was carried out using
the diphenylamine method (Burton, 1968). DNA was isolated
from the cell lines as previously described (Bell et al., 1981).
Synthetic oligonucleotides
The oligonucleotides were synthesised by the solid-phase
triester method. All of the probes were 20-mers with the
exception of K-ras codon 12, which was a 19-mer. The
oligonucleotide probes were 5' end labelled by phos-
phorylating with (T32P) ATP (Amersham, specific activity
> 5,000 Ci mmol-') and T4 polynucleotide kinase (Amer-
sham). They were purified by spin dialysis over I ml BioGel
P4 (BioRad) columns. Details of the oligonucleotides used
are as previously described (Farr et al., 1988). Briefly, probes
used were complementary to wild-type and mutant sequences
at H-ras codons 12 and 61, N-ras codons 12, 13 and 61 and
K-ras codons 12, 13 and 61.
In vitro amplification
One microgram DNA from each sample was amplified using
the polymerase chain reaction technique of Saiki et al. (1985).
Six pairs of primers designed to flank the regions of interest
were used simultaneously for amplification of H-, K- and
N-ras at positions 12, 13 and 61. Following an initial
denaturation step of 10 min at 98°C, 30 cycles of
amplification were carried out (one cycle being 2 min anneal-
ing at 37°C, 2 min extension at 37°C and 2 min denaturation
at 98°C). One unit of the Kienow fragment of DNA
polymerase (Amersham) was added after each annealing step.
An aliquot of the denatured final reaction mix, equivalent to
100 ng of the original DNA, was applied to Hybond N
(Amersham) under vacuum with BioDot apparatus (Bio
Rad). Hybridisation and washing conditions used are as
previously described (Farr et al., 1988). PCR amplified, non-
tumour DNA containing the c-ras normal gene sequence was
used as a control for adequate stringency of washing.
The effect of using six pairs of primers on the sensitivity of
individual amplifications is demonstrated for N-ras codon 61
in Figure 1. The intensity of signal decreased with increasing
numbers of primers, but was still suitable for detection after
overnight exposure to X-ray film. Similar results were
obtained with all wild-type probes. Adequate signals were
obtained with wild-type probes for most samples. In the
event of an amplification giving little or no signal, the PCR
was repeated using individual primer pairs. Only two samples
failed to amplify even after repeating the DNA isolations
from freshly cut sections.
Any sample hybridising with an oligonucleotide for a
variant of the normal ras gene sequence was reamplified
using individual sets of primers and the hybridisation
repeated. A number of false positives were found with H-ras
codon 12. This probably reflects the 'stickiness' of the GC
rich oligonucleotide probes. True positives were confirmed on
a fresh preparation of DNA from sections cut from the
original block.
A
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Figure 1 Effect of numbers of pairs of primers on amplification
reaction. Primers for N-ras codon 61 only A and B; primers for
N61, N12, K61, K12, H61 and H12 C and D. All hybridised with
N61 (wild-type) oligonucleotide. Source of DNA: A and C, high
molecular weight DNA; B and D, from a paraffin block.
Results
Variation in intensity of signal obtained with the wild-type
probes for H-ras codons 12 and 61, K-ras codons 12 and 61
and N-ras codons 12, 13 and 61 possibly reflects the quality
of the starting material. Agarose gel electrophoresis of
unamplified DNA isolated from paraffin blocks showed that
DNA was degraded with a size distribution from 24 to less
than 0.5 kb with the bulk less than 4 kb.
Point mutations were found in three samples: one cell ine
and two tumour specimens. In all cases the mutations were in
the 12th codon of the H-ras gene.
The first case, a squamous carcinoma of the larynx, had a
G to A transition at the second nucleotide of codon 12. This
leads to the substitution of the amino acid aspartate for
glycine in the ras protein. The same mutation was also found
in the cell line LICR-LON-HN8 which was established from
the primary tumour (Figure 2).
A tumour of the lip had two point mutations: G to A
transition and G to T transversion in the first nucleotide of
codon 12 resulting in substitution of serine or cystine respec-
tively for the normal glycine residue. A positive signal was
also obtained with wild-type oligonucleotide although this
was weaker than that obtained with either mutant probe
(Figure 3, tumour). This sample was taken from a block of
tissue assessed histologically to contain predominantly
tumour. On finding this result another block from the same
patient, processed at the same time as the first, was examined
and found to contain predominantly normal salivary gland
and connective tissue together with a small focus of tumour.
Sections from this block were amplified (Figure 3, normal +
tumour) and gave very weak signals with the mutant probes
compared to the wild type. The salivary gland was then
excised from this second block and amplified (Figure 3,
normal salivary gland). This hybridised only with the normal
H-ras codon 12 oligonucleotide. These results suggest that
H12WT H12Asp
LICR HN8
79/2804D
Control
Figure 2 Dot blot analysis of H12 amplified DNA from
squamous cell carcinoma cell line, LICR-LON-HN8 and paraffin
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Figure 3 Dot blot analysis of DNA from a paraffin block show-
ing a double point mutation of H12 in tumour DNA. H12 WT
and H12 cys, 24 h exposure. H12 ser, 48 h exposure. Tumour, amplified DNA from block containing primarily tumour. Normal
+ tumour, amplified DNA from second block containing
predominantly salivary gland showing a very weak signal with
mutant probes. Normal salivary gland, amplified DNA from
salivary gland excised from second block.
the tumour in the original block is clonal but contaminated
with normal tissue and that the contribution of tumour in the
section taken for the normal + tumour sample was minimal.
No hybridisation was found with oligonucleotides covering
all possible mutations of H-ras codon 61, K-ras codons 12
and 61 and N-ras 12, 13 and 61.
Discussion
Detection of point mutations in the ras oncogenes by
oligonucleotide hybridisation is a rapid and more sensitive
means of looking for activated oncogenes than mouse 3T3
transfection assay. Using such methods, activated ras has
been found associated with various types of human cancer
(Bos, 1988); for example K-ras with colon (Forrester et al.,
1987) and pancreatic cancer (Almoguera et al., 1988), H, K
and N-ras with thyroid neoplasms (Lemoine et al., 1989) and
N-ras with haemopoietic malignancy (Farr et al., 1988). The
presence of activated ras does not, however, appear to relate
to the prognosis of such tumours.
Recent developments in the isolation of tumour DNA
from tissue embedded in paraffin wax provides a means of
looking for changes in genes involved in the development of
genetic disease or malignancy with the advantage of knowing
the clinical outcome. Although the quality of DNA from this
source is generally poor in terms of size it is ideal for use in
the PCR technique (Ipraim et al., 1987). The two methods,
which together provide a powerful means of investigating
tissue samples, have been used previously to determine
human papilloma virus involvement in the development of
cervical cancer (Shibata et al., 1988) and the detection of
activated ras oncogenes in carcinomas of the human exocrine
pancreas (Almoguera et al., 1988).
Application of the PCR reaction in conjunction with
oligonucleotide probes has enabled us to look for activation
of ras oncogenes in small amounts of DNA which were
degraded and unsuitable for transfection assays. We have
been able to demonstrate that an activated ras oncogene
found in a squamous carcinoma cell line was also present in
the primary tumour from which that cell line was derived
and was not an artefact of culture.
Both of the tumours with activated ras genes and the
tissue from which the positive cell line was established had
received prior irradiation. It is therefore possible that these
results may reflect activation of the c-ras gene by
radiotherapy. It would be of interest to assess the effect of
y-irradiation on the ras gene family in human keratinocytes
and in secondary squamous carcinomas which sometimes
arise within the field of radiotherapy used to treat other
lesions.
If chemicals play a role in carcinogenesis in man, then, by
analogy with animal systems, human epithelial cells would be
a likely target for their action. The G to A transitions in the
H-ras gene in codon 12, described in two cases in this paper,
can arise by direct interaction of alkylating agents with
deoxyguanosine residues as has been described in rats
(Sukamar et al., 1983). However, from the work described
here and that of Rodenhuis et al. (1987), who found no ras
mutations in 15 squamous cell carcinomas of the lung, it
would seem that ras oncogene activation arising from either
chemical initiation or other causes is not a consistent occur-
rence in these epithelia. We have also not been able to
confirm a recent report by Ananthaswamy where four out of
eight tumours arising in sun-exposed sites were found to have
transforming activity in the NIH 3T3 nude mouse assay
(Ananthaswamy et al., 1988). It is possible that squamous
epithelium in different sites in the body varies in its suscep-
tibility to the effect of y-irradiation and ultraviolet light, but
application of the polymerase chain reaction and
oligonucleotide specific probes to archival material now
makes more extensive investigations on a large number of
samples possible. Future studies will therefore extend these
investigations in conjunction with in vitro analyses of the
effects of y-irradiation on human tissues.
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